Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case–Control Study

Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case–Control Study

Objectives: Interstitial lung disease (ILD) is an extra-articular manifestation in rheumatoid arthritis (RA), detected in 10.7% of patients, and causing a poor prognosis. Hence, biomarkers for ILD are urgently required in RA. Low molecular weight metabolites can be assessed by metabolomic analyses,...

Full description

Bibliographic Details
Main Authors: Hiroshi Furukawa, Shomi Oka, Kota Shimada, Akira Okamoto, Atsushi Hashimoto, Akiko Komiya, Koichiro Saisho, Norie Yoshikawa, Masao Katayama, Toshihiro Matsui, Naoshi Fukui, Kiyoshi Migita, Shigeto Tohma
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Medicine
Subjects:
rheumatoid arthritis
interstitial lung disease
metabolomics
usual interstitial pneumonia
non-specific interstitial pneumonia
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.599794/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2020.599794/full

Similar Items